Lp(a), ApoB and LDL: The Heart Tests Women Ask About

Medically reviewed by our medical team

Most women know their LDL number. Fewer have heard of ApoB or Lp(a), yet both names come up more often in midlife appointments and lab panels.

These are not competing tests. Each one describes a different part of the same picture, and the difference matters when you and your provider review your cardiovascular risk.

1. Why Are We Hearing More About ApoB and Lp(a)?

Cardiovascular risk assessment has moved past total cholesterol alone.

In March 2026, the ACC and AHA released a new dyslipidemia guideline that replaced the 2018 cholesterol guideline. It gives a larger role to additional markers. Lp(a), apolipoprotein B (apoB), high-sensitivity C-reactive protein, and triglycerides can all help refine an individual’s cardiovascular disease risk (American College of Cardiology, 2026).

The guideline also names reproductive markers as risk enhancers, including early menopause, preeclampsia, and gestational diabetes. That is one reason these conversations reach women during midlife.

2. What Does LDL Actually Measure?

LDL cholesterol, or low-density lipoprotein cholesterol, appears on almost every standard blood test.

Your liver packages cholesterol into particles that travel through your blood. LDL-C reports how much cholesterol those LDL particles carry, usually in mg/dL. When that number stays high over years, cholesterol can build up in artery walls.

LDL-C remains a central marker. Your provider still uses it, along with total cholesterol, HDL cholesterol, and triglycerides, to estimate your risk of heart disease.

A note on HDL: high-density lipoprotein has long been called the “good” cholesterol, but a favorable HDL number does not cancel out other risks.

3. What Is ApoB?

Apolipoprotein B is a protein that rides on the outside of atherogenic particles.

The Cleveland Clinic explains that apoB travels with LDL, VLDL, and similar particles, but never with HDL (Cleveland Clinic, n.d.). Each of those particles carries one apoB molecule.

So an ApoB test estimates how many plaque-forming particles circulate in your blood, rather than how much cholesterol sits inside them. In the 2026 guideline, apoB goals align with LDL targets at less than 55, 70, or 90 mg/dL, depending on risk category.

4. What Is Lp(a)?

Lipoprotein(a) is an LDL-like particle with an extra protein attached. Your genes set your level, and it stays fairly stable across your life.

The new guideline describes high Lp(a) as 125 nmol/L or greater, roughly 50 mg/dL. That level carries about a 1.4-fold higher long-term risk of heart attack or stroke. A level near 250 nmol/L at least doubles it. Diet and exercise barely move Lp(a), so repeat testing is generally unnecessary (American College of Cardiology, 2026).

This is the key point for patients. A healthy lifestyle and a normal LDL number do not tell you whether your Lp(a) is elevated. Only a blood test does.

5. Why Can These Numbers Tell Different Stories?

Picture delivery trucks carrying boxes.

LDL-C counts the boxes. ApoB counts the trucks. Two women can carry the same amount of cargo in a very different number of vehicles.

That is why two people with nearly identical LDL-C results can have different ApoB values. When particles are small and cholesterol-poor, LDL-C may look reassuring while the LDL particle count runs high. Lp(a) adds a third layer, because a standard panel does not detect it at all.

LDL vs. ApoB vs. Lp(a): What’s the Difference?

• LDL-C: how much cholesterol your LDL particles carry.
• ApoB: how many atherogenic particles are circulating.
• Lp(a): a largely inherited lipoprotein linked to cardiovascular risk.

6. Why Does Cardiovascular Health Matter During Menopause?

Menopause does not cause heart disease. Still, several risk factors shift during the transition.

An AHA scientific statement reports that LDL cholesterol and apoB tend to rise across the menopause transition, alongside vascular changes and a higher rate of metabolic syndrome. Body composition also changes, with more visceral fat and less lean muscle, even in women whose weight stays the same. Blood pressure, insulin, and glucose track more closely with chronological age (El Khoudary et al., 2020).

The authors describe midlife as a window for early prevention, not as a diagnosis. That framing is what makes cholesterol during menopause worth reviewing rather than assuming.

7. Should Every Woman Have ApoB and Lp(a) Tested?

The two tests answer different questions, so the guidance differs.

For Lp(a), the 2026 guideline recommends measurement at least once in adulthood for all adults. One result usually settles the question for life.

ApoB is more situational. It helps assess remaining risk in people with type 2 diabetes, high triglycerides, cardiovascular-kidney-metabolic syndrome, or known cardiovascular disease who have already reached their LDL-C goals. In those groups it may predict risk more accurately than LDL-C.

Either way, a single lab value decides nothing. Your provider reads it against your full risk profile.

8. What Should You Discuss With Your Provider?

Bring the context that gives your numbers meaning:

• Family history of early heart attack, stroke, or high cholesterol
• Your standard lipid panel, including total cholesterol and HDL cholesterol
• Blood pressure and blood sugar trends
• Smoking history, past and present
• Current medications and supplements
• Reproductive history, including age at menopause, preeclampsia, or gestational diabetes
• Whether an ApoB test, an Lp(a) test, or coronary calcium scoring fits your situation

Key Takeaway

LDL-C, ApoB, and Lp(a) measure three different things. Read together, they describe your cardiovascular risk more completely than any one of them alone.

Your cholesterol numbers are part of a bigger cardiovascular picture. Ask your healthcare provider whether your personal and family history suggests that additional risk assessment may be appropriate.

Start your hormonal assessment, or talk to the Care Team about your midlife health. Explore more in our education library and our menopause resources.

References

American College of Cardiology. (2026). ACC/AHA issue updated guideline for managing lipids, cholesterol.

Cleveland Clinic. (n.d.). Apolipoprotein B (ApoB) test.

El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., & Allison, M. A. (2020). Menopause transition and cardiovascular disease risk: Implications for timing of early prevention. Circulation, 142(25), e506–e532.